Vision-Sciences, Inc. Reports Net Sales of $3.7 Million for Second Quarter of Fiscal 2013
ORANGEBURG, N.Y., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the three- and six-month periods ended September 30, 2012, its second quarter and first half of fiscal 2013.